Header Logo

Connection

SHALINI MAKAWITA to Humans

Back to Details
This is a "connection" page, showing publications SHALINI MAKAWITA has written about Humans.
SHALINI MAKAWITA
Connection Strength
0.163
Humans
  1. Comprehensive Immunogenomic Profiling of IDH1-/2-Altered Cholangiocarcinoma. JCO Precis Oncol. 2024 Mar; 8:e2300544.
    View in: PubMed
    Score: 0.024
  2. Nonsurgical Management of Melanoma Brain Metastasis: Current Therapeutics, Challenges, and Strategies for Progress. Am Soc Clin Oncol Educ Book. 2021 Mar; 41:79-90.
    View in: PubMed
    Score: 0.020
  3. Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial. Future Oncol. 2020 Oct; 16(30):2375-2384.
    View in: PubMed
    Score: 0.019
  4. Antibody-Drug Conjugates: Patient and Treatment Selection. Am Soc Clin Oncol Educ Book. 2020 Mar; 40:1-10.
    View in: PubMed
    Score: 0.018
  5. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9. BMC Cancer. 2013 Sep 03; 13:404.
    View in: PubMed
    Score: 0.012
  6. Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Mol Cell Proteomics. 2011 Oct; 10(10):M111.008599.
    View in: PubMed
    Score: 0.010
  7. The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification. Clin Chem. 2010 Feb; 56(2):212-22.
    View in: PubMed
    Score: 0.009
  8. Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors. Pediatr Dev Pathol. 2009 Mar-Apr; 12(2):127-35.
    View in: PubMed
    Score: 0.008
  9. Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma. Front Immunol. 2024; 15:1324093.
    View in: PubMed
    Score: 0.006
  10. Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancer. Cell Rep Med. 2023 04 18; 4(4):101013.
    View in: PubMed
    Score: 0.006
  11. Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based Chemotherapy. Clin Cancer Res. 2022 06 01; 28(11):2229-2236.
    View in: PubMed
    Score: 0.005
  12. Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast Brazil. Oncologist. 2022 05 06; 27(5):344-351.
    View in: PubMed
    Score: 0.005
  13. Concurrent Chemo-radiation As a Means of Achieving Pathologic Complete Response in Triple Negative Breast Cancer. Clin Breast Cancer. 2022 06; 22(4):e536-e543.
    View in: PubMed
    Score: 0.005
  14. It's not a mystery, it's in the history: Multidisciplinary management of multiple endocrine neoplasia type 1. CA Cancer J Clin. 2021 09; 71(5):369-380.
    View in: PubMed
    Score: 0.005
  15. Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait. BMC Cancer. 2019 Oct 17; 19(1):965.
    View in: PubMed
    Score: 0.004
  16. Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery. BMC Med. 2012 Apr 19; 10:39.
    View in: PubMed
    Score: 0.003
  17. Mining the malignant ascites proteome for pancreatic cancer biomarkers. Proteomics. 2011 Dec; 11(23):4551-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.